Physician

Amit Bhagwanji Patel, M.D.

According to 2025 Medicare claims, Amit Patel, M.D. (NPI: 1316208093) practices family practice in the Memphis, TN-MS-AR market, with the plurality of this provider's patient population coming from Tate, MS. This provider's primary affiliated billing organization is PRAVINCHANDRA P. PATEL, MD P.C. (NPI: 1457527475; TIN: 640925177) and primary practice location at 38618-3915.

Patel's data goes back to 2015 and runs through 2024. For example, in 2024, this provider had 599 traditional Medicare patients, billed 16,210 HCPCS/CPT codes, and received $359,267 in Medicare payments. The top billing code was 99214 (Established patient office or other outpatient visit with moderate level of decision making, if using time, 30 minutes or more). Part D data shows 20,794 prescription claims across 1,339 beneficiaries totaling $3,090,656 in drug costs, led by Mounjaro (Tirzepatide). DME data shows 184 claims. Open Payments data shows 178 records totaling $4,422. You can download detailed data with all billing codes (2015-2024). For more recent data, please contact us.

Over the past 10 years, this provider's Medicare Part B carrier billing has risen steadily, from $28,742 to $359,267. Similarly, Part D prescription costs have moved sharply higher in recent years, from $24,821 to $3,090,656. In contrast, DME billing represents a smaller volume and moved sharply higher in recent years, from $87 to $43,547.

Part B Carrier Billing Trend

Medicare payment trend, with N of patients and claim lines in the table.

Year	Patients	Clm Lines	Payment
2015	348	381	$28,742
2016	429	493	$41,098
2017	409	637	$49,596
2018	459	694	$56,213
2019	473	2,348	$73,443
2020	574	4,669	$143,144
2021	513	6,365	$182,215
2022	504	7,754	$203,093
2023	415	7,473	$182,212
2024	599	16,210	$359,267

Part D Events Trend

Drug cost trend, with N of patients and prescription claims in the table.

Year	Patients	Claims	Drug Cost
2015	110	558	$24,821
2016	108	159	$1,636
2017	49	55	$1,389
2018	208	531	$23,014
2019	773	6,059	$392,216
2020	979	14,368	$1,041,376
2021	1,091	14,280	$1,435,611
2022	1,233	17,160	$1,979,197
2023	1,210	22,010	$3,218,408
2024	1,339	20,794	$3,090,656

DME Billing Trend

Medicare payment trend, with N of patients and DME claim records in the table.

Year	Patients	Claims	Payment
2015	N/R	N/R	N/R
2016	N/R	N/R	N/R
2017	N/R	N/R	N/R
2018	N/R	N/R	N/R
2019	N/R	N/R	N/R
2020	48	98	$5,263
2021	N/R	64	$5,211
2022	N/R	166	$6,144
2023	14	229	$13,449
2024	19	184	$19,192

* / # = suppressed by CMS; 0 = reported zero; N/R = not reported or blank.

Top 5 Part B carrier billing codes in 2024

By total payments.

Code	Description	Patients	Clm Lines	Total Payment
99214	Established patient office or other outpatient visit with moderate level of decision making, if using time, 30 minutes or more	515	2,267	$86
99213	Established patient office or other outpatient visit with low level od decision making, if using time, 20 minutes or more	245	449	$59
80305	Testing for presence of drug, read by direct observation	286	1,514	$12
G2211	Visit complexity inherent to evaluation and management associated with medical care services that serve as the continuing focal point for all needed health care services and/or with medical care services that are part of ongoing care related to a patient's	320	1,449	$12
36415	Insertion of needle into vein for collection of blood sample	297	660	$8

Top 5 Part D drugs in 2024

By total drug costs.

Drug	Generic	Claims	Total Day Supply	Total Drug Cost
Mounjaro	Tirzepatide	412	14,033	$501,730
Ozempic	Semaglutide	249	10,234	$325,829
Trelegy Ellipta	Fluticasone/Umeclidin/Vilanter	184	8,550	$176,514
Linzess	Linaclotide	174	7,950	$138,830
Jardiance	Empagliflozin	116	7,036	$137,736

Top 5 DME services in 2024

By Total Medicare Payment Amount.

HCPCS Code	HCPCS Description	Supplier Rental Indicator	Total Supplier Beneficiaries	Total Supplier Claims	Total Medicare Payment Amount
A4239	Supply allowance for non-adjunctive, non-implanted continuous glucose monitor (cgm), includes all supplies and accessories, 1 month supply = 1 unit of service	N	N/R	34	$15,551
E1390	Oxygen concentrator, single delivery port, capable of delivering 85 percent or greater oxygen concentration at the prescribed flow rate	Y	N/R	24	$1,526
Q0513	Pharmacy dispensing fee for inhalation drug(s); per 30 days	N	N/R	17	$440
A4253	Blood glucose test or reagent strips for home blood glucose monitor, per 50 strips	N	19	37	$420
E0630	Patient lift, hydraulic or mechanical, includes any seat, sling, strap(s) or pad(s)	Y	N/R	12	$370

Open Payments Summary in 2024

Category	Definition	Records	Total Reported Amount	Top Related Entity
General Payments	Reported payment or transfer-of-value amount.	178	$4,422	Janssen Pharmaceuticals, Inc
Research Payments	Reported research-related payment or transfer-of-value amount.	0	$0	N/R
Ownership / Investment Interests	Reported value of ownership or investment interests.	0	$0	N/R

Explore More Providers

FAQ

What Medicare data is available for Amit Bhagwanji Patel, M.D.?

Tedicare shows public-source Medicare data for Amit Bhagwanji Patel, M.D. (NPI 1316208093), including provider identity, specialty, market context, Medicare Part B activity, Part D prescribing, DME records, Open Payments where available, billing organization details, and ACO affiliation signals where available. Profile data covers 2015-2024, with current attribution based on 2025 claims where available.

Does Amit Bhagwanji Patel, M.D. have ACO affiliation data?

No ACO affiliation record is shown in the available Tedicare data for this profile.

What billing organization is linked to Amit Bhagwanji Patel, M.D.?

Amit Bhagwanji Patel, M.D. is linked to PRAVINCHANDRA P. PATEL, MD P.C. (billing NPI 1457527475) in the available physician profile data.

Does Amit Bhagwanji Patel, M.D. have Open Payments data?

Amit Bhagwanji Patel, M.D. has 178 connected Open Payments records in the available 2024 summary data.

Can I download physician-level Medicare data from Tedicare?

Yes. Tedicare provides sample physician export data and paid custom physician data exports for research, planning, outreach, and market analysis. Exports can include physician profile fields, market and specialty context, billing organization details, ACO affiliation signals where available, and Medicare utilization data.